Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis

@article{Brutocao2018PsychiatricDI,
  title={Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis},
  author={Claire Brutocao and Feras Zaiem and Mouaz Alsawas and Allison S. Morrow and Mohammad Hassan Murad and A. P. Javed},
  journal={Endocrine},
  year={2018},
  volume={62},
  pages={318-325}
}
PurposePolycystic ovary syndrome (PCOS) is a common disorder affecting up to 15% of women in the reproductive age. [] Key Method The purpose of this study is to examine the prevalence of any psychiatric disorder in women with PCOS.MethodsWe searched MEDLINE, Embase, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Scopus through February 08, 2017 for studies that examined the prevalence of any psychiatric disorder in adolescents or adults with a clinical or…

The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis

  • Yulu WangZhihong NiKeyi Li
  • Medicine, Psychology
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2021
TLDR
The authors' meta-analysis confirmed that women with PCOS had a high prevalence of anxiety and depression of different severity, with mild symptoms being more common.

[Mental disorders and personality characteristics of patients with polycystic ovary syndrome].

TLDR
Women with PCOS have an increased risk of developing mental disorders, which indicates the need to connect psychological and psychiatric support to their medical management.

Polycystic Ovary Syndrome, Affective Symptoms, and Neuroactive Steroids: a Focus on Allopregnanolone

TLDR
Prospective studies evaluating associations between psychiatric symptoms and NAS are needed to elucidate the biological causes of the increased rates of psychiatric symptoms among women with PCOS and inform clinical treatment, and allopregnanolone, with its role in normal reproductive function, menstrual dysregulation, makes it a particularly intriguing candidate for future investigation.

The Relationship between Polycystic Ovary Syndrome and Psychological Symptoms

TLDR
Women with PCOS are at risk for anxiety and depression and the need of emotional support into clinical process with appropriate interventions as an additional therapy to improve life quality for women withPCOS is emerged.

Assessment of Optimism in Women with Polycystic Ovary Syndrome: A Case Control-Study

TLDR
Evidence is provided that a personality characteristic with important implications in illness prognosis may be affected in PCOS, and it is proposed to assess dispositional optimism with the LOT-R scale in the gynecological appointment and tailor medical attention accordingly as a way to improve the comprehensive care of patients within a multidisciplinary team.

Polycystic Ovary Syndrome and Risk of Five Common Psychiatric Disorders Among European Women: A Two-Sample Mendelian Randomization Study

TLDR
In European populations, PCOS may be a causal factor in OCD, but not AD, BIP, MDD, or SCZ, while genetically predicted OCD was not associated with PCOS.

Lifestyle interventions and quality of life for women with polycystic ovary syndrome

TLDR
An update of systematic review is conducted to examine the effects of lifestyle interventions on health-related quality of life or general quality oflife in women with PCOS.

Risk of schizophrenia in patients with polycystic ovary syndrome: a nationwide population-based cohort study from Taiwan

TLDR
This study shows PCOS patients are at increased risk of incident schizophrenia, and the metformin treatment has a protective effect against incident schizophrenia.
...

References

SHOWING 1-10 OF 40 REFERENCES

Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis.

BACKGROUND Our aim was to assess differences in anxiety and depression between women with and without (controls) polycystic ovary syndrome (PCOS). METHODS We conducted a systematic review and

Depression and Anxiety in Polycystic Ovary Syndrome: Etiology and Treatment

TLDR
Screening for anxiety and depression is recommended in women with PCOS at the time of diagnosis and treatment of PCOS-related symptoms with lifestyle modification and/or oral contraceptive pills may be of benefit.

Epidemiology, diagnosis, and management of polycystic ovary syndrome

TLDR
Proper diagnosis and management of PCOS is essential to address patient concerns but also to prevent future metabolic, endocrine, psychiatric, and cardiovascular complications.

Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index.

TLDR
Several anxiety symptoms distinguished women with PCOS from a control group matched on BMI, and a better understanding of the symptoms is needed to identify and alleviate anxiety symptoms in this vulnerable group.

The effect of polycystic ovary syndrome on health-related quality of life

  • S. CoffeyH. Mason
  • Medicine, Psychology
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2003
TLDR
Encouragingly, treatment for acne and OSAS improved the HRQoL, although treatment for hirsutism did not, and Quantitative studies on the effect of PCOS on HRZoL and the benefit of treatments need to be conducted.

Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review.

TLDR
It appears that weight concerns have a particular negative impact upon HRQoL, although the role of body mass index in affecting HRZoL scores is inconclusive from the available evidence.

Mood and anxiety disorders in women with PCOS